Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Diagnostics (Basel, Switzerland)|January 11, 2025
Diagnostic Efficacy of <sup>123</sup>Iodo-Metaiodobenzylguanidine SPECT/CT in Cardiac vs. Neurological Diseases: A Comparative Study of Arrhythmogenic Right Ventricular Cardiomyopathy and α-SynucleinopathiesJohannes M Hagen, Maximilian Scheifele, Mathias J Zacherl, et al.
Blood|January 29, 2000
Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet productionM Peck-Radosavljevic, M Wichlas, J Zacherl, et al.
Molecular Imaging and Biology|September 30, 2025
Peptide Receptor Radionuclide Therapy with Lu-177-DOTATATE and Monitoring with Somatostatin Receptor PET/CT in Patients with Advanced Differentiated Thyroid CarcinomaSophie Carina Kunte, Vera U Wenter, Adrien Holzgreve, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 26, 2026
Prognostic Value of Early Follow-Up PSMA PET/CT After 2 Cycles of [<sup>177</sup>Lu]Lu-PSMA RPT in Patients with mCRPC: Comparison with PSA DynamicsLiam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
Diagnostics (Basel, Switzerland)|August 28, 2025
Prognostic Value of Automated Bone Scan Index (aBSI) in Patients with mCRPC Undergoing Three vs. Six Cycles of <sup>223</sup>Ra TherapySophie C Siegmund, Harun Ilhan, Antonia Gerull, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 1, 2025
Refining the clinical utility of [<sup>177</sup>Lu]Lu/[<sup>225</sup>Ac]Ac-PSMA tandem RLT in patients with metastatic castration resistant prostate cancerLiam Widjaja, Johannes Hornfeck, Sophie C Siegmund, et al.
EJNMMI Reports|October 30, 2025
Feasibility of different lymph node metastases delineation approaches in [<sup>18</sup>F]SiTATE PET/CT imaging in NET patientsSophie Carina Siegmund, Magdalena Schöll, Vera U Wenter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 10, 2021
Outcome after PSMA-PET/CT-based salvage radiotherapy for nodal recurrence after radical prostatectomyPaul Rogowski, Christian Trapp, Rieke von Bestenbostel, et al.
Cancers|May 14, 2025
Comparison of the Hematotoxicity of PRRT with Lutathera<sup>®</sup> and Locally Manufactured <sup>177</sup>Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application IntervalsMarkus Hofmann, Sophie C Kunte, Marcus Unterrainer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 15, 2026
Estimation of split renal function on PET using the SSTR-targeting radioligands [<sup>18</sup>F]SiTATE, [<sup>68</sup>Ga]Ga-DOTA-TATE and [<sup>68</sup>Ga]Ga-DOTA-TOC in a theranostic settingMaximilian Tiling, Lena M Unterrainer, Sophie C Siegmund, et al.
Pageof 9